Susquehanna International Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-58,100
| Closed | -$914K | – | 13514 |
|
|
2024
Q1 | $914K | Sell |
58,100
-23,617
| -29% | -$364K | ﹤0.01% | 7123 |
|
|
2023
Q4 | $1.32M | Buy |
81,717
+9,192
| +13% | +$117K | ﹤0.01% | 6312 |
|
|
2023
Q3 | $923K | Buy |
72,525
+19,917
| +38% | +$275K | ﹤0.01% | 6802 |
|
|
2023
Q2 | $741K | Sell |
52,608
-61,145
| -54% | -$875K | ﹤0.01% | 7389 |
|
|
2023
Q1 | $1.76M | Buy |
113,753
+87,068
| +326% | +$1.45M | ﹤0.01% | 5428 |
|
|
2022
Q4 | $437K | Sell |
26,685
-44,918
| -63% | -$730K | ﹤0.01% | 8218 |
|
|
2022
Q3 | $1.32M | Buy |
71,603
+60,251
| +531% | +$946K | ﹤0.01% | 5904 |
|
|
2022
Q2 | $149K | Sell |
11,352
-141,764
| -93% | -$1.56M | ﹤0.01% | 11033 |
|
|
2022
Q1 | $1.42M | Sell |
153,116
-127,261
| -45% | -$1.08M | ﹤0.01% | 6276 |
|
|
2021
Q4 | $2.74M | Buy |
280,377
+209,362
| +295% | +$3.94M | ﹤0.01% | 4813 |
|
|
2021
Q3 | $2.41M | Sell |
71,015
-2,284
| -3% | -$72.9K | ﹤0.01% | 5433 |
|
|
2021
Q2 | $2.68M | Buy |
73,299
+46,669
| +175% | +$1.81M | ﹤0.01% | 5280 |
|
|
2021
Q1 | $1.19M | Sell |
26,630
-22,297
| -46% | -$1.04M | ﹤0.01% | 7254 |
|
|
2020
Q4 | $2.79M | Sell |
48,927
-13,850
| -22% | -$821K | ﹤0.01% | 4424 |
|
|
2020
Q3 | $3.22M | Buy |
62,777
+48,232
| +332% | +$2.36M | ﹤0.01% | 3734 |
|
|
2020
Q2 | $869K | Sell |
14,545
-45,941
| -76% | -$2.46M | ﹤0.01% | 6224 |
|
|
2020
Q1 | $2.49M | Sell |
60,486
-21,065
| -26% | -$1.17M | ﹤0.01% | 3583 |
|
|
2019
Q4 | $5.08M | Buy |
81,551
+43,734
| +116% | +$2.08M | ﹤0.01% | 2950 |
|
|
2019
Q3 | $1.28M | Buy |
37,817
+23,621
| +166% | +$699K | ﹤0.01% | 5160 |
|
|
2019
Q2 | $320K | Buy |
+14,196
| New | +$332K | ﹤0.01% | 8183 |
|
|
2018
Q3 | – | Sell |
-9,001
| Closed | -$333K | – | 10450 |
|
|
2018
Q2 | $354K | Buy |
+9,001
| New | +$265K | ﹤0.01% | 7508 |
|
Other funds holding DCPH
Susquehanna International Group's DCPH Position: Q2 2024 in Review
Susquehanna International Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 58,100 shares — an estimated $914K sold.
Susquehanna International Group first reported a position in DCPH in Q2 2018 and held it in 21 quarters. The position peaked at $5.08M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Susquehanna International Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Susquehanna International Group sold 58,100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $914K.
- Susquehanna International Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- Susquehanna International Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.08M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.